Brief: Clearmind Advances Dialogue With U.S. Federal Government On Psychedelic Therapies, Submitting Recommendations To FDA
07/10/2026 13:46
BRIEF-Clearmind Advances Dialogue With U.S. Federal Government On Psychedelic Therapies, Submitting Recommendations To FDA Oct 7 (Reuters) - Clearmind Medicine Inc CMND.O:
CLEARMIND ADVANCES DIALOGUE WITH U.S. FEDERAL GOVERNMENT ON PSYCHEDELIC THERAPIES, SUBMITTING RECOMMENDATIONS TO FDA
CLEARMIND MEDICINE - CALLS FOR RESEARCH AND CLINICAL COLLABORATIONS WITH VA, DOW, AND HHS
Source text: ID:nGNX77HZy7
Further company coverage: CMND.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearmind Medicine
See all newsBrief: Clearmind Advances Dialogue With U.S. Federal Government On Psychedelic Therapies, Submitting Recommendations To FDA
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM